Page: 15 of 30 11 12 13 14 15 16 17 18 19

Dr Susan E M Clarke - Consultant Physician and Senior Lecturer Guy’s and St Thomas' NHS Foundation Trust Kings College London UK Channel: www.ecancer.tv Length: 0 Date: April 23, 2010 www.ecancer.tv

Ms Kate Farnell - Founder/Director 'Butterfly North East Registered Charity no:1108932, Patient Thyroid Cancer Advisor, N.C.C.T, Visiting Lecturer in Nursing Northumbria University Channel: www.ecancer.tv Length: 0 Date: April 23, 2010 www.ecancer.tv

Professor Dion Morton Channel: www.ecancer.tv Length: 0 Date: April 23, 2010 www.ecancer.tv

Dr Gary Middleton Channel: www.ecancer.tv Length: 0 Date: April 23, 2010 www.ecancer.tv

Dr John Bridgewater - UCL Channel: www.ecancer.tv Length: 0 Date: April 23, 2010 www.ecancer.tv

Dr Tamas Hicklish - Dorset Cancer Centre UK Channel: www.ecancer.tv Length: 0 Date: April 23, 2010 www.ecancer.tv

Professor Shirley Hodgson - St George’s Hospital Channel: www.ecancer.tv Length: 0 Date: April 23, 2010 www.ecancer.tv

Anna Vanazzi - European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Dr Vanazzi discusses the trial investigating radioimmunotherapy with Y-90-ibritumomab tiuxetan in extranodal marginal zone lymphoma, a disease tha...

Dr Tomas Rejda - AMC, the Netherlands. Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Dr Rejda discusses programmes devised to help people return to work after recovering from cancer.

Dr. Sibylle Loibl - University of Frankfurt and German Breast Group Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Dr Loibl talks about research indicating that using cytotoxic agents to treat pregnant women with breast cancer does not pose a threat to their unb...

Dr Patricia Ganz - School of Public Health and the David Geffen School of Medicine, UCLA, Los Angeles Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Professor Ganz discusses the post-treatment symptoms found in women who have survived breast cancer and the importance of managing these symptoms.

Prof John Yarnold - Institute of Cancer Research and Royal Marsden Hospital, UK Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Technical advances can lead to benefits for women, for instance marking areas most at risk of relapse to allow targeted radiotherapy, and using a ...

Prof Niall O’Higgins - Royal College of Surgeons in Ireland, Bahrain Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Professor O’Higgins, discusses the advantages of a centralised breast care services and his experiences helping to develop the national service in...

Dr Kristina Desmedt - Jules Bordet Institute, Brussels Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Kristina Desmedt discusses research that attempts to predict the efficacy of anthracyclines. The results of this study validate the use of topoisom...

Dr Alison Jones - Dept of Medical Oncology, Royal Free Hospital, London Channel: www.ecancer.tv Length: 0 Date: April 22, 2010 Dr Jones discusses the use of Trastuzumab (trade name Herceptin) and Lapatinib as drugs to target the HER2 receptor and the possibility of combinin...

Dr Thierry Andre - Hopital Tenon, Paris, France Channel: www.ecancer.tv Length: 0 Date: April 20, 2010 A study comparing FOLFIRI regimens with FOLFIRI plus panitumumab showed a two month increase in progression free survival among the patients with w...

Jola Gore-Booth - Europacolon, France / UK Channel: www.ecancer.tv Length: 0 Date: April 20, 2010 Ms Gore-Booth discusses the work of Europacolon and the challenges that have been faced raising awareness of colorectal cancer across Europe, the ...

Professor Jan Willem Leer - Joint Centre for Radiation Oncology, Nijmegen, the Netherlands Channel: www.ecancer.tv Length: 0 Date: April 20, 2010 Prof. Leer discusses the use of radiotherapy before rectal surgery, which part of rectum should be treated with preoperative radiotherapy and outl...

Professor Eric van Cutsem - University of Leuven, Belgium Channel: www.ecancer.tv Length: 0 Date: April 20, 2010 Professor van Cutsem discusses the importance of molecular markers in clinical practice, what factors are important in deciding the best treatment...

Professor Cornelis van de Velde - Professor of Surgical Oncology at the Leiden University Medical Center, Leiden, the Netherlands. Channel: www.ecancer.tv Length: 0 Date: April 19, 2010 Professor van de Velde offers an update on the progress of their international trial investigating whether preoperative radiotherapy is necessary w...

Page: 15 of 30 11 12 13 14 15 16 17 18 19